Federal Supply Schedule 36F79720D0151
Award Date
8/1/20
Last Date to Order
7/31/25
Federal Agency
Veterans Integrated Service Network 12
Awardee
Janssen Products, LP
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The U.S. Department of Veterans Affairs (VA) awarded a $3.7 million Blanket Purchase Agreement (BPA) to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., a large pharmaceutical manufacturer. The BPA allows VA medical facilities to place firm fixed price call orders for the oncology medications BALVERSA (erdafitinib) and Belzutifan (WELIREG) through July 2024. This streamlined procurement vehicle supports the VA's Veterans Health Administration (VHA) in maintaining a steady...
This Blanket Purchase Agreement (BPA) is a single-award federal contract Indefinite Delivery Vehicle (IDV) awarded by the Department of Veterans Affairs (VA) to Janssen Products LP, doing business as Ortho Biotech Products, LP. The BPA has a ceiling value of $216,355 and a period of performance through July 31, 2025. The primary purpose of this BPA is to provide the VA with the antitubercular medication Sirturo (bedaquiline). Janssen Products LP, a subsidiary of Johnson & Johnson,...
The Federal Supply Schedule (FSS) contract with Janssen Pharmaceuticals, Inc. provides branded pharmaceutical and medical products to the U.S. Department of Veterans Affairs (VA) through the Veterans Integrated Service Network 12 (VISN 12). The $4.41 billion, multiple-award contract has a period of performance from September 2024 to September 2029. As the prime contractor, Janssen has received multiple firm fixed-price task orders to supply various medications and medical supplies, including...
The federal contract IDV award is a multiple award blanket purchase agreement between the Department of Veterans Affairs Veterans Health Administration and Janssen Biotech, Inc. The BPA utilizes Janssen's Pharmaceuticals and Drugs Federal Supply Schedule, referred to as FSS-61-IB, to provide for the delivery of Balversa and Belzutifan medications to various Veterans Integrated Service Networks. Delivery locations under the BPA include Carrollton, Texas; Chelsea, Maine; and Horsham,...
This Blanket Purchase Agreement (BPA) was awarded by the National Acquisition Center, a component of the U.S. Department of Veterans Affairs (VA), to Janssen Biotech Inc. (doing business as Centocor Ortho Biotech Inc.). The $15,000,000 single-award BPA has a period of performance from September 2024 through September 2025 and is for the provision of the oncology drugs BALVERSA (erdafitinib) and CARVYKTI (ciltacabtagene autoleucel). Janssen Biotech is a major pharmaceutical manufacturer that...
The Federal Supply Schedule contract number 36F79719D0228 was awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs to Johnson & Johnson Health Care Systems Inc. (JJHCS), a division of Johnson & Johnson. This multiple-award contract, which runs through September 28, 2024, is under the Pharmaceuticals and Drugs (FSS-61-IB) Federal Supply Schedule and has a ceiling value of $2,730,579,390.00. Under this contract, JJHCS provides a wide...
This federal contract Indefinite Delivery Vehicle (IDV) is a multiple-award Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB) awarded by the U.S. Department of Veterans Affairs (VA) to Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc. The $3.1 billion IDV has an ultimate completion date of August 31, 2029 and enables the VA and its Veterans Integrated Service Networks (VISNs) to efficiently procure critical oncology and specialty medications to...
This Federal Supply Schedule contract was awarded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the U.S. Department of Veterans Affairs, to Johnson & Johnson Health Care Systems Inc. (JJHCS), a division of the Johnson & Johnson corporation. The $114.3 million multiple-award contract covers a wide range of medical and surgical products, including orthopedic and spinal implants, surgical instruments, biological products, powered surgical staplers, and...
The U.S. Department of Veterans Affairs (VA) has awarded Sandoz Inc., a Novartis subsidiary, an indefinite delivery vehicle (IDV) under the Federal Supply Schedule for Pharmaceuticals and Drugs (FSS-61-IB). The contract, valued at $16.85 billion, allows the VA, Department of Defense, Bureau of Prisons, and Indian Health Services to order a variety of pharmaceutical products from Sandoz's commercial catalog, including antibiotics, chemotherapy drugs, ophthalmic solutions, psychiatric medications,...
The U.S. Department of Veterans Affairs (VA) has awarded a single-award Blanket Purchase Agreement (BPA) to Ferring Pharmaceuticals Inc., a for-profit manufacturer of pharmaceutical goods, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The $5.96 million BPA, with a period of performance through March 2026, enables the VA to procure the drug Adstiladrin (nadofaragene firadenovec), a treatment for genitourinary cancers, to support the provision of healthcare services to...